Insider trade

CFO exercised or converted 7,654 BMY derivative securities

Traded Mar 10, 2026 · Filed Mar 12, 2026

Bristol Myers SquibbBMY

7,654
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 10, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 12, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001451604-26-000002

Filed / recorded

Mar 12, 2026, 8:13 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BRISTOL MYERS SQUIBB CO

Issuer CIK

14272

Ticker

BMY

Reporting person

David V Elkins

Relationship

Officer

Officer title

EVP, Chief Financial Officer

Security

Common Stock, $0.10 par value

Table

Non-derivative (Table I)

Transaction date

Mar 10, 2026

Transaction code

M

Shares / units

7,654

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

175,033

Ownership form

Direct

Amendment

No

Footnotes from the filing

Represents vesting of one-quarter of market share units granted on March 10, 2022.

Around the same time

6mo ago

3,307Shares

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

6mo ago

1,692Shares · @ $61.73

Routine share withholding; mechanical by default.

Why it stands out Official record

6mo ago

3,307Derivative units

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record